UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
35.01
+0.86 (2.52%)
Oct 20, 2026, 4:00 PM EDT - Market closed
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.71 billion as of October 20, 2026. It is the 7,364th most valuable company in the world and the 1,875th biggest in the United States. Its market cap has increased by 118.22% in one year.
Market Cap
1.71B
Enterprise Value
1.80B
1-Year Change
118.22%
Global Rank
Country Rank
#1,875 United States
Category
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.71B, an increase of 840.80%. That is a compound annual growth rate of 26.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.71B | 56.10% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 1.79B |
| Zymeworks | 1.78B |
| Maravai LifeSciences Holdings | 1.76B |
| Palvella Therapeutics | 1.73B |
| Xencor | 1.70B |
| Septerna | 1.70B |
| Trevi Therapeutics | 1.69B |
| Vir Biotechnology | 1.69B |